A new series of analogs Hexagamavunon-6 (HGV-6) was preparedand screened for antibacterial activity against Streptococcus mutans (ATCC 25175), Escherichia coli (ATCC 25922), Bacillus subtilis(ATCC 6633), Psedomonas aeruginosa (ATCC 27853), Klebsiella pneumoniae and Enterococcus faecalis (ATCC 29212) using disc diffusion method. The antibacterial results showed that 3,5-Bis-(2',4'-dichlorobenzilyden)-N-methyl-4-piperidone (1c) compound display significant inhibition and broad-spectrum antibacterial activity. This is accordance with the in silico evaluation showing that 1c compound has a lower docking score than both 1a and 1b compound. None of the tested compounds was as active as the reference standard drug Amoxicillin.
Key words: Analog curcumin; Hexagamavunon-6; 3,5-Bis-(2',4'-dichlorobenzilyden)-N-methyl-4-piperidone; antibacterials activity; disc diffusion.
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
We use cookies and other tracking technologies to work properly, to analyze our website traffic, and to understand where our visitors are coming from. More InfoGot It!
